MARIA PARKER: Open Payments
NPI 1487233094 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 42 payments from 15 companies in 2025. Trend: 2023 $437 · 2024 $825 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $102 |
| Indivior Inc. | 3 | $96 |
| Abbott Laboratories | 4 | $95 |
| Alkermes, Inc. | 3 | $84 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Braeburn Inc. | 1 | $23 |
| Renalytix AI, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, FREESTYLE LIBRE 3, MAVYRET, VIVITROL, REXULTI, ARISTADA.
Industry payments across AZ — which companies pay providers there.
